Correlation Between Pfizer and Companhia Paranaense

Can any of the company-specific risk be diversified away by investing in both Pfizer and Companhia Paranaense at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Companhia Paranaense into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pfizer Inc and Companhia Paranaense de, you can compare the effects of market volatilities on Pfizer and Companhia Paranaense and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Companhia Paranaense. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Companhia Paranaense.

Diversification Opportunities for Pfizer and Companhia Paranaense

0.44

Correlation Coefficient

Pfizer  Companhia Paranaense

Very weak diversification

The 3 months correlation between Pfizer and Companhia is 0.44. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Companhia Paranaense de in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Companhia Paranaense and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Companhia Paranaense. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Companhia Paranaense has no effect on the direction of Pfizer i.e., Pfizer and Companhia Paranaense go up and down completely randomly.

Pair Corralation between Pfizer and Companhia Paranaense

Considering the 90-day investment horizon Pfizer is expected to generate 1.09 times less return on investment than Companhia Paranaense. But when comparing it to its historical volatility, Pfizer Inc is 1.25 times less risky than Companhia Paranaense. It trades about 0.09 of its potential returns per unit of risk. Companhia Paranaense de is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  883.00  in Companhia Paranaense de on September 13, 2025 and sell it today you would earn a total of  87.00  from holding Companhia Paranaense de or generate 9.85% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Pfizer Inc  vs.  Companhia Paranaense de

Pfizer Inc

Risk-Adjusted Performance

Fair

Compared to the overall equity markets, risk-adjusted returns on investments in Pfizer Inc are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady technical and fundamental indicators, Pfizer may actually be approaching a critical reversion point that can send shares even higher in January 2026.

Companhia Paranaense

Risk-Adjusted Performance

Fair

Compared to the overall equity markets, risk-adjusted returns on investments in Companhia Paranaense de are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady basic indicators, Companhia Paranaense may actually be approaching a critical reversion point that can send shares even higher in January 2026.

Pair Trading with Pfizer and Companhia Paranaense

The main advantage of trading using opposite Pfizer and Companhia Paranaense positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Companhia Paranaense can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Companhia Paranaense will offset losses from the drop in Companhia Paranaense's long position.

The idea behind Pfizer Inc and Companhia Paranaense de pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.